| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


* From the Departamentos de Anestesiología
y Farmacología Clínica Hospital Universitario "La Paz" Facultad de Medicina Universidad Autónoma de Madrid Madrid Spain
Address correspondence to: Dr. Francisco Reinoso-Barbero, Coordinador Médico de la Unidad de Dolor Infantil, Departamento de Anestesiología, Hospital Infantil "La Paz", Paseo de la Castellana 261, 28046 Madrid. Phone: +349 1727 7315; Fax: +349 1727 7033; E-mail: FREINOSO{at}santandersupernet.com
| Abstract |
|---|
|
|
|---|
Methods: In a prospective, double-blind study, 30 children, ASA III, 216-yr-old, were randomly allocated to receive immediately after surgery either epidural F-L (epidural infusion at a rate of 0.10.35 mLkg1hr1 of 1 µgmL1 of fentanyl and lidocaine 0.4%) or epidural M (bolus of 20 µgkg1 of morphine in 0.5 mLkg1 saline every eight hours). Both groups received 40 mgkg1 of iv metamizol (dipyrone) every six hours. In the F-L Group, blood samples were taken on the second and third postoperative day to determine total lidocaine concentrations. Adequacy of analgesia using adapted pediatric pain scales (010 score) and side-effects were assessed every eight hours postoperatively.
Results: Resting pain scores were under 4, 95% of the time in the F-L Group and 87% of the time in the M Group (Chi square=4.674, P <0.05). The frequency of complications was very similar in both groups. The F-L Group total plasma lidocaine concentrations were directly related to the dose received, and below the toxic range in all patients.
Conclusions: Postoperative epidural fentanyl with lidocaine infusion provides slightly better analgesia than conventional bolus administration of epidural morphine. Side-effects or risk of systemic toxicity were not augmented by the addition of lidocaine to epidural opioids.
| Introduction |
|---|
|
|
|---|
Local anesthetic drugs can be added safely to opioids for postoperative analgesia.3 The most common agents for postoperative epidural analgesia are bupivacaine and ropivacaine.4 Although lidocaine is chemically related to these amide local anesthetics and has been extensively used in pediatric patients,5 we are unaware of published clinical experience using lidocaine as a local anesthetic agent in postoperative epidural analgesia.
The aim of this study was to evaluate the efficacy and safety of a mixture of lidocaine (0.4%) plus 1 µgmL1 of fentanyl used as a continuous postoperative epidural analgesia in a pediatric population that had undergone major orthopedic surgery when compared to our standard practice of administering epidural boluses of morphine (20 µgkg1).
| Methods |
|---|
|
|
|---|
Following induction of anesthesia the child was placed in the lateral position and, using the loss of resistance technique, the epidural space was detected at the L4L5 interspace. A 19 or 20-gauge epidural catheter was introduced via an 18 or 19-gauge Tuohy needle. Depending on location of surgery the patients received 0.10.5 mLkg1 of bupivacaine 0.25% with epinephrine. The maximum bolus was 20 mL.
Epidural drug administration was initiated on the postoperative ward, using a standardized continuous epidural infusion of lidocaine 0.4% with fentanyl 1 µgmL1 at an initial rate similar to the successful intraoperative epidural volume employed per hour with an initial bolus of 0.5 mLkg1 of saline every eight hours in the F-L Group.
The M Group received a standardized continuous epidural infusion of saline at an initial rate similar to the successful intraoperative epidural volume employed per hour with an initial bolus of 0.5 mLkg1 of morphine in saline (40 µgmL1). Epidural drugs were prepared by nurses who did participate in the evaluation of the children.
All the children who had epidural catheters were cared for in one of several, appropriately staffed, designated wards. Postoperative pain control was standardised and included routine recording of heart rate, blood pressure, respiratory rate and pulse oxymetry, pain score, and incidence of nausea or vomiting and pruritus every eight hours.6 Analgesia was scored in all cases from 0 to 10. Children who were older than six years or were cooperative scored their pain on a visual analogue scale (0 corresponded to no pain and 10 to the worst imaginable pain). Children under six years or who could not express themselves, were observed according to the parameters of the "LLANTO" scale,7 an adapted and validated Spanish objective pain scale (in which scores also range from 0 to 10). In both groups, if pain scores were not below 2, the rate of continuous epidural infusion was augmented in 0.05 mLkghr1 increments simultaneous to the augmentation in the volume of epidural boluses in 0.05 mLkg1 increments. The maximum increases permitted were up to 0.35 mLkghr1 of continuous infusion and 0.75 mLkg1 every eight hours of bolus administration. If any pain score had remained >5, iv fentanyl would have been prescribed, the epidural infusion discontinued and the patient would have been excluded from the study. IV metamizol (dypirone - see discussion) (40 mgkg1) was administered regularly every six hours in both groups.
The volume of epidural infusion per hour and the volume of epidural boluses administered were recorded. The times of initiation and discontinuation of the epidural analgesia were documented. The mean epidural infusion rate and mean dose of epidural morphine were calculated in each group.
Two millilitres of blood were extracted on the morning of the second and third postoperative days to determine the total plasma lidocaine concentration. The blood was centrifuged and stored at -20°C until analysis.
Demographic and parametric data were expressed as mean ± standard deviation. Parametric data were analyzed using the paired ANOVA test. Non-parametric data were analyzed using Chi square. P <0.05 was accepted as statistically significant.
| Results |
|---|
|
|
|---|
Demographic data did not differ between groups (Table I
). The type of surgery performed on the children in the study is listed in Table II
.
|
|
Nursing staff recorded pain level a total of 108 times in the F-L Group and on 108 occasions also in the M Group patients (Figure 1
). Pain control was considered satisfactory when pain scores were below 4. Satisfactory pain control was more frequent in the L-F Group (95% occasions) than in M Group (87%; Chi square= 4.674, P <0.05).
|
|
|
|
| Discussion |
|---|
|
|
|---|
The frequency of adverse side-effects, such as nausea and vomiting or pruritus, observed in the F-L Group, was similar to that found when employing our usual postoperative analgesic epidural morphine doses.12 The addition of systemic doses of a drug like metamizol with a well-established analgesic activity that, like ketorolac, inhibits prostaglandine synthesis, but has a different safety profile, probably allowed decreased doses of epidural drugs and, in this way, decreased the incidence of adverse effects.13
The incidence of lower limb weakness (Table III
) observed in our study during lidocaine infusion was lower than in other series.14 Only one child presented severe motor blockade (equivalent to levels 3 and 4 on the Bromage scale), and it is possible that mild motor blockade was not observed in very young or uncooperative patients. However, almost all LF Group patients were able to walk and move almost in the same way as those in the M Group. Thus, despite its capacity to produce a very strong motor block at high concentrations, lidocaine maintains its analgesic properties and does not present this adverse effect when used in low concentrations and in combination with epidural fentanyl and iv metamizol.
The clinical toxicity of lidocaine depends on plasma levels.15 Substantial inter-individual variations in plasmatic lidocaine concentrations were recorded in our patients, but in no sample did this measurement even approach toxic levels (Figures 2 and 3![]()
). The highest lidocaine plasma level observed in our study was 3.8 µgmL 1 , while the average was 1.7 µgmL1. This concentration has been associated with beneficial effects like anti-arrhythmia and positive inotropism.
Continuous epidural infusion of lidocaine in pediatric patients did not have any significant cumulative effect on plasma concentrations in this study; on the other hand, bupivacaine, another common local anesthetic, has a demonstrated potential for systemic toxicity in very young patients.16
In the future, double-blind prospective and randomized studies comparing different local anesthetic agents (bupivacaine vs lidocaine vs ropivacaine) or different analgesic techniques (continuous perfusion vs NPCA-PCA) will help us to identify the ideal analgesic agents and the best method of administration in this patient population.
In summary, the use of a continuous epidural infusion of lidocaine (0.4%) and fentanyl (1 µgmL1), in combination with iv metamizol (40 mgkg1) provided slightly better pain control than our usual regimen of epidural morphine (20 µgkg1 q 8 hr), also in combination with iv metamizol (40 mgkg1) during the first three postoperative days in healthy children (216 yr of age) undergoing orthopedic surgery without increasing the incidence of adverse side-effects or systemic toxicity.
| Acknowledgments |
|---|
|
|
|---|
Revision received September 26, 2001. Accepted for publication May 7, 2001.
| References |
|---|
|
|
|---|
2
Karl HW, Tyler DC, Krane EJ. Respiratory depression after low-dose caudal morphine. Can J Anaesth 1996; 43: 10657.
3 Wulf H, Winckler K, Maier CH, Heinzow B. Pharmacokinetics and protein binding of bupivacaine in postoperative epidural analgesia. Acta Anaesthesiol Scand 1988; 32: 5304.[Medline]
4 Scott DA, Emanuelsson B-M, Mooney PH, Cook RJ, Junestrand C. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia. Anesth Analg 1997; 85: 132230.[Abstract]
5 Stayer SA, Pasquariello CA, Schwartz RE, Balsara RK, Lear BR. The safety of continuous pleural lignocaine after thoracotomy in children and adolescents. Paediatr Anaesth 1995; 5: 30710.[Medline]
6 Brenn BR, Rose JB. Pediatric pain services: monitoring for epidural analgesia in the non-intensive care unit setting. Anesthesiology. 1995; 83: 4323.[Medline]
7 Herreras JL, Reinoso-Barbero F, Pérez-Scharnowska H, Alonso FJ, Hervilla S, Borges JJ. Escala "Llanto": nueva escala de medida de dolor agudo en pediatría. Rev Esp Anestesiol Reanim 1999; 46: 1601.
8
Carr AS, Fear DW, Sikich N, Bissonnette B. Bupivacaine 0.125% produces motor block and weakness with fentanyl epidural analgesia in children. Can J Anaesth 1998; 45: 105460.
9
Yaster M, Tobin JR, Billett C, Casella JF, Dover G. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Pediatrics 1994; 93: 3105.
10 Wajima Z, Shitara T, Ishikawa G, Kaneko K, Inoue T, Ogawa R. Analgesia after upper abdominal surgery using extradural administration of a fixed dose of buprenorphine in combination with lignocaine given at two infusion rates: a comparative study. Acta Anaesthesiol Scand. 1997; 41: 10615.[Medline]
11 Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL. Concentration-effect relationship of intravenous lidocaine on the allodinia of complex regional pain syndrome types I and II. Anesthesiology 2000; 92: 7583.[Medline]
12 Kart T, Walther-Larsen S, Svejborg TF, Feilberg V, Eriksen K, Rasmussen M. Comparison of continuous epidural infusion of fentanyl and bupivacaine with intermittent epidural administration of morphine for postoperative pain management in children. Acta Anaesthesiol Scand 1997; 41: 4615.[Medline]
13
Montes A, Warner W, Puig MM. Use of intravenous patient-controlled analgesia for the documentation of synergy between tramadol and metamizol. Br J Anaesth 2000; 85: 21723.
14
Wood CE, Goresky GV, Klassen KA, Kuwahara B, Neil SG. Complications of continuous epidural infusions for postoperative analgesia in children. Can J Anaesth. 1994; 41: 61320.
15 Mather LE, Cousins MJ. Local anaesthetics and their current clinical use. Drugs 1979; 18: 185205.[Medline]
16
Peutrell JM, Holder K, Gregory M. Plasma bupivacaine concentrations associated with continuous extradural infusions in babies. Br J Anaesth 1997; 78: 1602.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |